Sequenta's Series B - II Round

Sequenta raised a round of funding on February 23, 2012.

Sequenta, formerly MLC Dx, is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. Sequ…

Articles about Sequenta's Series B - II Round: